BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32459973)

  • 21. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
    Mao G; Mu Z; Wu DA
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1484-1494. PubMed ID: 34605863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway.
    Zhao Q; Sun P; Qin S; Liu J
    Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W; Zhang Q; Cui Q; Xu Y
    Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of
    Yao LZ; Zhu YL; Liu JJ
    Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
    Chen H; Wei L; Luo M; Wang X; Zhu C; Huang H; Liu X; Lu H; Zhong Y
    Cell Biol Toxicol; 2022 Dec; 38(6):995-1011. PubMed ID: 34322788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
    Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
    Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
    Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
    Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.
    Xi H; He Z; Lv C
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J
    J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
    He W; Jin H; Liu Q; Sun Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation.
    Hu J; Pan J; Luo Z; Duan Q; Wang D
    Cancer Gene Ther; 2021 Jun; 28(6):602-618. PubMed ID: 33204001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11.
    Yang F; Wang F; Gao ZS; Quang GQ; Hu HB; Zheng M
    Kaohsiung J Med Sci; 2023 Feb; 39(2):134-144. PubMed ID: 36354184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-424-5p inhibits the proliferation, migration, and invasion of nasopharyngeal carcinoma cells by decreasing AKT3 expression.
    Zhao C; Zhao F; Chen H; Liu Y; Su J
    Braz J Med Biol Res; 2020; 53(7):e9029. PubMed ID: 32520206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 Induces Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway.
    Fei Z; Deng Z; Zhou L; Li K; Xia X; Xie R
    Oncol Res; 2019 Jul; 27(7):801-807. PubMed ID: 30982497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.